3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Colorectal Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Thyroid Cancer, Papillary
1
Thymoma
1
Surgery
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Neoadjuvant Chemoimmunotherapy
1
Myasthenia Gravis
1
Menstruation Disturbances
1
Lymphatic Metastasis
1
Leiomyoma
1
Invasive Breast Carcinoma
1
Gastrointenstinal Stromal Tumor (GIST)
1
Esophageal Neoplasms
1
Endometriosis
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Adenomyosis
1
Interventions
Paclitaxel
69
Bevacizumab
62
Carboplatin
53
pembrolizumab
46
olaparib
32
Specimen Handling
27
Gemcitabine
27
Cyclophosphamide
26
Magnetic Resonance Spectroscopy
24
liposomal doxorubicin
22
Cisplatin
21
niraparib
20
Taxes
18
Nivolumab
18
fludarabine
17
Topotecan
17
Biopsy
17
Doxorubicin
14
Immunoglobulin G
12
Fulvestrant
12
Disulfides
12
Oxaliplatin
10
mirvetuximab soravtansine
9
durvalumab
9
aldesleukin
9
Surveys and Questionnaires
9
Ipilimumab
9
Fluorouracil
9
Blood Specimen Collection
9
cemiplimab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Robotic Surgical Procedures
×
1 year
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled